Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1992 2
1993 4
1994 2
1995 1
1998 3
1999 3
2000 2
2001 3
2002 4
2003 2
2004 3
2005 1
2006 5
2007 8
2008 5
2009 4
2010 2
2011 1
2012 4
2013 5
2014 1
2015 4
2016 2
2017 3
2018 1
2019 4
2020 4
2021 7
2022 10
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
[Physiological aging spine].
Vital JM, Sénégas J, Bouloussa H, Liguoro D. Vital JM, et al. Among authors: liguoro d. Rev Prat. 2021 May;71(5):497-508. Rev Prat. 2021. PMID: 34553527 French.
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.
Castaldo V, Minopoli M, Di Modugno F, Sacconi A, Liguoro D, Frigerio R, Ortolano A, Di Martile M, Gesualdi L, Madonna G, Capone M, Cirombella R, Catizone A, Del Bufalo D, Vecchione A, Carriero MV, Ascierto PA, Mancini R, Fattore L, Ciliberto G. Castaldo V, et al. Among authors: liguoro d. J Exp Clin Cancer Res. 2023 Nov 27;42(1):317. doi: 10.1186/s13046-023-02878-9. J Exp Clin Cancer Res. 2023. PMID: 38008717 Free PMC article.
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma.
Ruggiero CF, Fattore L, Terrenato I, Sperati F, Salvati V, Madonna G, Capone M, Valenti F, Di Martino S, Mandoj C, Liguoro D, Castaldo V, Cafaro G, Simeone E, Vanella V, Russillo M, Conti L, Cuda G, Giannarelli D, Ascierto PA, Mancini R, Ciliberto G. Ruggiero CF, et al. Among authors: liguoro d. Theranostics. 2022 Oct 24;12(17):7420-7430. doi: 10.7150/thno.77761. eCollection 2022. Theranostics. 2022. PMID: 36438490 Free PMC article.
Intraorbital apocrine hidrocystoma.
Vignes JR, Franco-Vidal V, Eimer S, Liguoro D. Vignes JR, et al. Among authors: liguoro d. Clin Neurol Neurosurg. 2007 Sep;109(7):631-3. doi: 10.1016/j.clineuro.2007.05.011. Epub 2007 Jun 29. Clin Neurol Neurosurg. 2007. PMID: 17601659
Intramedullary Spinal Cord Lesions: A Single-Center Experience.
Jecko V, Roblot P, Mongardi L, Ollivier M, Piccoli ND, Charleux T, Wavasseur T, Gimbert E, Liguoro D, Chotard G, Vignes JR. Jecko V, et al. Among authors: liguoro d. Neurospine. 2022 Mar;19(1):108-117. doi: 10.14245/ns.2143190.595. Epub 2022 Mar 31. Neurospine. 2022. PMID: 35378585 Free PMC article.
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance.
Fattore L, Cafaro G, Di Martile M, Campani V, Sacconi A, Liguoro D, Marra E, Bruschini S, Stoppoloni D, Cirombella R, De Nicola F, Pallocca M, Ruggiero CF, Castaldo V, Catizone A, Del Bufalo D, Viglietto G, Vecchione A, Blandino G, Aurisicchio L, Fanciulli M, Ascierto PA, De Rosa G, Mancini R, Ciliberto G. Fattore L, et al. Among authors: liguoro d. Oncogene. 2023 Jan;42(4):293-307. doi: 10.1038/s41388-022-02547-9. Epub 2022 Nov 23. Oncogene. 2023. PMID: 36418472 Free PMC article.
103 results